POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life. The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex. These devices are used to test cardiac biomarkers, blood coagulation, platelet function, HIV, hemoglobin concentration, ad five-part differential blood count.
Technavio's analysts forecast the POCT market in the US to grow at a CAGR of 5.88% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the POCT market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of POCT diagnostic devices. The market is segmented based on application: Blood glucose testing Infectious disease testing Cardiac markers testing Pregnancy and fertility testing Blood gas/electrolyte testing Tumour markers testing Urinalysis testing Cholesterol testing
Technavio's report, POCT Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the key vendors in the market. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.
North America free trade agreement For a full, detailed list, view our report
Limitation of POCT products For a full, detailed list, view our report
Key role of USAMRIID For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2019 and what will the growth rate be What are the key market trends What is driving this market What are the challenges to market growth Who are the key vendors in this market space What are the market opportunities and threats faced by the key vendors What are the strengths and weaknesses of the key vendors
Technavio Announces the Publication of its Research Report POCT Market in the US 2015-2019
Technavio recognizes the following companies as the key players in the POCT Market in the US: Abbott Diagnostics, Alere, Roche Diagnostics and Siemens
Other Prominent Vendors in the market are: Abaxis, Acon Laboratories, Avioq, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, Hologic, Thermo Fisher Scientific, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Sysmex, Trivitron Healthcare, and URIT.
Commenting on the report, an analyst from Technavios team said: The current market trends such as the introduction of low-cost microfluidic devices will also fuel market growth. The development of POCT devices with nano or microfluidic technologies is an emerging tool by which to detect infectious diseases. For instance, SurModics has incorporated this technology into a few of its IVD products. This technology will reduce the cost of the product as it requires less reagent and consumes less power.
According to the report, the growth of the POCT market in the US is driven by numerous factors, one of which is the NAFTA. This agreement has increased the US exports of diagnostics and has reduced the tariffs and has opened its procurement market in Mexico and Canada, which has reduced trade barriers and increased sales in these region. It has helped the US to compete with other countries such as Germany and Japan.
Further, the report states that the development of an integrated POCT product is a major challenge for vendors because of the limited lifespan of the biomolecules that need to be tested and the quality control issues associated with POCT devices.